mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |